Switzerland

16 April 2026 Niederer Kraft Frey acted as lead counsel to UBS Switzerland AG as mandated lead arranger, bookrunner and agent and the other members of the banking syndicate in connection with a CHF 120 million credit financing for the DentaCore Group. Founded in 2021, DentaCore Group has built a vertically integrated dental platform that has rapidly expanded to a network of over 60 operating locations and laboratories across Switzerland. The NKF team was led by Transaction partners Adrian Koller and Philip Spoerlé, working with associates Lorenzo Henseler, Carlotta Ulmer and Alexander Züger, junior associates Barbara Bürgi and Matthias Schmid (all Transactions) and counsel Marc Vogelsang (Tax).

March 23 2026 AECOM acquired Consigli, a leading Norwegian AI company transforming engineering and early-stage project design. The Homburger team advising AECOM on this transaction comprised Andreas Müller, Luca Ellenberger and Thierry Burckhardt (all Corporate / M&A), Laetitia Fracheboud (Tax), Luca Dal Molin and Joel Fink (both IP / IT) as well as Allegra Arnold (Competition).     Contact Wanda Schweda / Marketing / [email protected]

10 April 2026 Niederer Kraft Frey advised Luzerner Kantonalbank AG acting as arranger, agent and security agent and the other members of the banking syndicate in connection with a refinancing for HOCHDORF Swiss Nutrition AG. HOCHDORF Swiss Nutrition AG is a Swiss market leader in milk processing, specialising in infant nutrition, powder and mixing technology for milk-based and alternative proteins. The NKF team was led by Transactions partners Adrian Koller and Ulysses von Salis, working with associate Alexander Züger and junior associate Barbara Bürgi (both Transactions), as well as counsel Marc Vogelsang (Tax).

2 April 2026 Niederer Kraft Frey advised SHL Medical AG on its refinancing by a broad syndicate of lenders led by UBS Switzerland AG as mandated lead arranger, agent and security agent. Founded in 1989 and headquartered in Switzerland, SHL Medical AG is a world-leading provider of drug delivery solutions, such as autoinjectors, and a trusted partner to global pharmaceutical companies and biotech firms across 75 markets worldwide. The NKF team was led by Transaction partners Adrian Koller and Philip Spoerlé, working with associate Carlotta Ulmer and junior associate Barbara Bürgi (both Transactions).